STOCK TITAN

Vext to Announce Financial Results for Q4 and Fiscal 2023 on April 25, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Vext Science, Inc. (VEXTF) to announce financial results for Q4 and Fiscal 2023 on April 25, 2024. The U.S.-based cannabis operator with operations in Arizona and Ohio will host a conference call to discuss the results.
Positive
  • None.
Negative
  • None.

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the period ended December 31, 2023, before market open on April 25, 2024.

The Company will also host a conference call and webcast on Thursday, April 25, 2024 at 8:00 a.m. ET to discuss the financial results for the fourth quarter and full year 2023.

CONFERENCE CALL DETAILS

Date: April 25, 2024 | Time: 8:00am ET

Participant Dial-in: 416-915-3239 or 1-800-319-4610

Replay Dial-in: 1-800-319-6413

Conference ID: 10023409

Playback #: 0865 (Expires on May 9, 2024)

Listen to webcast: https://www.gowebcasting.com/13320

A replay of the conference call and webcast will be available on Vext's investor website following the conclusion of the call. For more details, contact the IR team at investors@vextscience.com.

About Vext Science, Inc.

Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio, as well as through Vext's partnerships in other states. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations, with the Company having operated profitably since 2016. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.

Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.

For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands

Forward-Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements regarding future developments and the business and operations of the Vext, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at www.sedarplus.ca.

Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Eric Offenberger
Chief Executive Officer
844-211-3725

For further information:
Jonathan Ross, Vext Investor Relations
jon.ross@loderockadvisors.com
416-244-9851

SOURCE: Vext Science, Inc

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/205414

FAQ

When will Vext Science announce its financial results for Q4 and Fiscal 2023?

Vext Science will announce its financial results for Q4 and Fiscal 2023 on April 25, 2024.

What is the ticker symbol for Vext Science?

The ticker symbol for Vext Science is VEXTF.

Where are Vext Science's operations located?

Vext Science has operations in Arizona and Ohio.

When is the conference call to discuss the financial results scheduled?

The conference call to discuss the financial results is scheduled for April 25, 2024, at 8:00 a.m. ET.

How can I listen to the webcast of the conference call?

You can listen to the webcast of the conference call at https://www.gowebcasting.com/13320.

VEXT SCIENCE INC

OTC:VEXTF

VEXTF Rankings

VEXTF Latest News

VEXTF Stock Data

34.05M
61.23M
45.8%
0.36%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Phoenix